Rein Therapeutics, Inc. (RNTX)
0.58
-0.03
(-5.23%)
USD |
NASDAQ |
Nov 06, 10:07
Rein Therapeutics Price to Book Value : 4.877 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 5.146 |
| November 04, 2026 | 5.539 |
| November 03, 2026 | 5.613 |
| November 02, 2026 | 5.343 |
| October 30, 2026 | 5.634 |
| October 29, 2026 | 6.11 |
| October 28, 2026 | 6.010 |
| October 27, 2026 | 5.922 |
| October 26, 2026 | 4.904 |
| October 23, 2026 | 4.895 |
| October 22, 2026 | 5.066 |
| October 21, 2026 | 5.254 |
| October 20, 2026 | 5.004 |
| October 19, 2026 | 4.642 |
| October 16, 2026 | 4.964 |
| October 15, 2026 | 5.281 |
| October 14, 2026 | 4.928 |
| October 13, 2026 | 6.345 |
| October 12, 2026 | 6.600 |
| October 09, 2026 | 6.677 |
| October 08, 2026 | 6.469 |
| October 07, 2026 | 6.632 |
| October 06, 2026 | 6.937 |
| October 05, 2026 | 6.937 |
| October 02, 2026 | 6.733 |
| Date | Value |
|---|---|
| October 01, 2026 | 7.165 |
| September 30, 2026 | 6.761 |
| September 29, 2026 | 6.643 |
| September 28, 2026 | 6.063 |
| September 25, 2026 | 6.293 |
| September 24, 2026 | 6.256 |
| September 23, 2026 | 6.478 |
| September 22, 2026 | 6.683 |
| September 21, 2026 | 6.681 |
| September 18, 2026 | 6.727 |
| September 17, 2026 | 6.636 |
| September 16, 2026 | 5.904 |
| September 15, 2026 | 5.949 |
| September 14, 2026 | 6.652 |
| September 11, 2026 | 6.601 |
| September 10, 2026 | 6.567 |
| September 09, 2026 | 6.958 |
| September 08, 2026 | 7.253 |
| September 04, 2026 | 7.476 |
| September 03, 2026 | 7.094 |
| September 02, 2026 | 6.515 |
| September 01, 2026 | 6.330 |
| August 31, 2026 | 6.306 |
| August 28, 2026 | 6.408 |
| August 27, 2026 | 6.583 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.756 |
| Alnylam Pharmaceuticals, Inc. | 5.852 |
| Anika Therapeutics, Inc. | 1.638 |
| Savara, Inc. | 6.534 |
| Vericel Corp. | 7.116 |
Price to Book Value Related Metrics
| Price | 0.58 |
| Earnings Yield | -296.2% |
| Market Cap | 49.74M |